Stay updated on Biogen Press Releases

Sign up to get notified when there's something new on the Biogen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Biogen Press Releases page

  1. Check
    3 days ago
    Change Detected
    Summary
    Adds a July 29, 2026 news item announcing Biogen Reports Second Quarter 2026 Results. Removes the June 4, 2026 item Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy, reducing the page's archive of past releases.
    Difference
    4%
    Check dated 2026-08-01T14:18:52.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The News page now lists several new July 12–15, 2026 press releases, including a leadership appointment and LEQEMBI updates; older notices such as stockholder communications and conference announcements have been removed from the listing.
    Difference
    4%
    Check dated 2026-07-18T03:49:42.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A new July 7, 2026 entry announcing Biogen's AAIC webcast on July 14, 2026 was added. The May 14, 2026 press release about Biogen's acquisition of Apellis Pharmaceuticals was removed.
    Difference
    4%
    Check dated 2026-07-10T23:56:41.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A new June 29, 2026 news item was added announcing Biogen's plan to highlight its Alzheimer’s portfolio at AAIC 2026, including Phase 2 CELIA data for Diranersen. The May 14, 2026 topline results entry for the CELIA study of Diranersen was removed.
    Difference
    4%
    Check dated 2026-07-03T21:52:28.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Two new News items were added for June 17 (Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.) and June 16 (Biogen to Report Second Quarter 2026 Financial Results July 29, 2026). Two older May updates (FDA Priority Review of LEQEMBI subcutaneous dose and Bank of America conference participation) were removed.
    Difference
    4%
    Check dated 2026-06-19T17:52:51.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    New 2026 press releases were added (including FDA Breakthrough Designation for Salanersen, EULAR update on Dapirolizumab Pegol, and upcoming kidney presentations) and older 2026 items (first-quarter results, acquisition-related items, and related agreements) were removed from the list.
    Difference
    5%
    Check dated 2026-06-05T09:32:48.000Z thumbnail image

Stay in the know with updates to Biogen Press Releases

Enter your email address, and we'll notify you when there's something new on the Biogen Press Releases page.